menu search

turnstone biologics corp. reports second quarter 2023 financial results and provides business update

Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position e...

September 1, 2023, 9:57 pm

: turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range

turnstone Biologics Corp. TSBX is headed for its public debut Friday, as the San Diego-based biotechnol...

July 21, 2023, 12:20 pm

turnstone biologics set to go public as upsized $80 million ipo pricing at low end of expected range

turnstone Biologics Corp. TSBX, is headed for its public debut Friday, as the San Diego-based biotechno...

July 21, 2023, 8:20 am

turnstone biologics corp. announces pricing of upsized initial public offering

SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — turnstone Biologics Corp. (“...

July 21, 2023, 6:15 am

Ipo update: turnstone biologics readies $75 million ipo plan

turnstone Biologics Corp. has filed proposed terms for a $75.4 million IPO. The firm is developing drug...

July 17, 2023, 3:06 pm

turnstone biologics to offer 5.8 million shares in planned ipo priced at $12 to $14 each

turnstone Biologics TSBX, , a clinical-stage biotech that specializes in treatments for solid tumors, s...

July 17, 2023, 6:35 am


Search within

Pages Search Results: